Cleary Gottlieb represented Blackstone (NYSE: BX) in the formation of Blackstone Life Sciences V (BXLS V), the inaugural Blackstone fund in life sciences.
BXLS V was oversubscribed and closed at its hard cap with $4.6 billion of total capital commitments —the largest life sciences private fund raised to date.
Blackstone Life Sciences is a private, global investment platform with capabilities to invest across the life-cycle of companies and products within the key life science sectors. By combining scale investments and hands-on operational leadership, Blackstone Life Sciences helps bring to market promising new medicines that improve patients’ lives.
For more information, please see the press release here.